BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1568044)

  • 1. Lysinuric protein intolerance presenting deficiency of argininosuccinate synthetase.
    Ono N; Kishida K; Tokumoto K; Watanabe M; Shimada Y; Yoshinaga J; Fujii M
    Intern Med; 1992 Jan; 31(1):55-9. PubMed ID: 1568044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysinuric protein intolerance.
    Simell O; Perheentupa J; Rapola J; Visakorpi JK; Eskelin LE
    Am J Med; 1975 Aug; 59(2):229-40. PubMed ID: 1155480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lysine infusion on urea cycle in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Mattila K; Simell O
    Metabolism; 2000 May; 49(5):621-5. PubMed ID: 10831173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperammonemia in lysinuric protein intolerance.
    Kato T; Mizutani N; Ban M
    Pediatrics; 1984 Apr; 73(4):489-92. PubMed ID: 6424086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dibasic amino acid metabolic disorders].
    Shimizu H
    Nihon Rinsho; 1992 Jul; 50(7):1555-60. PubMed ID: 1404883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent stupor due to lysinuric protein intolerance.
    Moosa NV; Minal D; Rao AN; Kumar A
    Neurol India; 2005 Sep; 53(3):333-4. PubMed ID: 16230804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of combined lysinuric protein intolerance and hypoactivity of argininosuccinate synthetase (citrullinemia)].
    Shioya K; Yamamura Y; Kurihara T; Matsukura S
    Nihon Naika Gakkai Zasshi; 1988 May; 77(5):667-73. PubMed ID: 3145960
    [No Abstract]   [Full Text] [Related]  

  • 8. Periodic hyperammonemia, hyperlysinemia, and homocitrullinuria associated with decreased argininosuccinate synthetase and arginase activities.
    Sogawa H; Oyanagi K; Nakao T
    Pediatr Res; 1977 Sep; 11(9 Pt 1):949-53. PubMed ID: 904980
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lysinuric protein intolerance: a severe hyperammonemia secondary to l-arginine deficiency (author's transl)]].
    Coude FX; Ogier H; Charpentier C; Cathelineau L; Grimber G; Parvy P; Saudubray JM; Frezal J
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():829-35. PubMed ID: 6800334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocitrullinuria and homoargininuria in lysinuric protein intolerance.
    Kato T; Sano M; Mizutani N
    J Inherit Metab Dis; 1989; 12(2):157-61. PubMed ID: 2474087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An adult-onset case of argininosuccinate synthetase deficiency presenting with atypical citrullinemia.
    Osafune K; Ichikawa K; Yasui T; Sekikawa A; Takeoka H; Kanatsu K; Kohigashi K; Koshiyama H
    Intern Med; 1999 Jul; 38(7):590-6. PubMed ID: 10435367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral supplementation corrects plasma lysine concentrations in lysinuric protein intolerance.
    Lukkarinen M; Näntö-Salonen K; Pulkki K; Aalto M; Simell O
    Metabolism; 2003 Jul; 52(7):935-8. PubMed ID: 12870174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine, an indispensable amino acid for patients with inborn errors of urea synthesis.
    Brusilow SW
    J Clin Invest; 1984 Dec; 74(6):2144-8. PubMed ID: 6511918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases.
    Jan D; Poggi F; Jouvet P; Rabier D; Laurent J; Beringer A; Hubert P; Saudubray JM; Revillon Y
    Transplant Proc; 1994 Feb; 26(1):188. PubMed ID: 8108934
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term oral lysine supplementation in lysinuric protein intolerance.
    Tanner LM; Näntö-Salonen K; Niinikoski H; Huoponen K; Simell O
    Metabolism; 2007 Feb; 56(2):185-9. PubMed ID: 17224331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necropsy findings in lysinuric protein intolerance.
    McManus DT; Moore R; Hill CM; Rodgers C; Carson DJ; Love AH
    J Clin Pathol; 1996 Apr; 49(4):345-7. PubMed ID: 8655715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Basolateral" and mitochondrial membrane transport defect in the hepatocytes in lysinuric protein intolerance.
    Rajantie J; Simell O; Perheentupa J
    Acta Paediatr Scand; 1983 Jan; 72(1):65-70. PubMed ID: 6407277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of urea cycle intermediates in lysinuric protein intolerance: effect on plasma and urinary arginine and ornithine.
    Rajantie J; Simell O; Perheentupa J
    Metabolism; 1983 Jan; 32(1):49-51. PubMed ID: 6401349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysinuric protein intolerance. Urinary amino acid excretion at 2 and 9 days of age.
    Candito M; Vianey-Saban C; Ferraci JP; Bébin B; Chazalette JP; Sebag F; Mathieu M; Chambon P
    J Inherit Metab Dis; 1994; 17(2):252-3. PubMed ID: 7967486
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of glucagon on urinary excretion of urea and on plasma ammonia level in argininosuccinate synthetase deficiency.
    Tamura S; Kawata S; Fukuda K; Inui Y; Kakimoto H; Ishiguro H; Namba M; Kono N; Matsuzawa Y
    J Gastroenterol; 1994 Feb; 29(1):31-4. PubMed ID: 8199693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.